Search research articles
Contact Us
Filters
Showing results (141-150 of 460) with videos related to
Page
of 46
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
February 5, 2017
Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age
Binod Dhakal, Ariel Nelson, Guru Subramanian Guru Murthy, et al.
Hematology/Oncology and Stem Cell Therapy
|
October 15, 2020
Bronchoalveolar lavage-based COVID-19 testing in patients with cancer
Muhammad Bilal Abid, Saurabh Chhabra, Blake Buchan, et al.
Cytotherapy
|
October 18, 2015
Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use
Lauren Veltri, Aaron Cumpston, Alexandra Shillingburg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2015
A phase I study of midostaurin and azacitidine in relapsed and elderly AML patients
Brenda W Cooper, Tamila L Kindwall-Keller, Michael D Craig, et al.
Transplantation and Cellular Therapy
|
June 29, 2022
Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Miguel-Angel Perales, Larry D Anderson, Tania Jain, et al.
Leukemia & Lymphoma
|
October 25, 2008
Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma
Mehdi Hamadani, Farrukh T Awan, Patrick Elder, et al.
Bone Marrow Transplantation
|
August 10, 2023
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning
Shanze Arshad, Xi Fang, Kwang W Ahn, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 17, 2022
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
Paolo F Caimi, Kirit M Ardeshna, Erin Reid, et al.
Plos One
|
July 23, 2011
CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells
Kechang Liu, Bryan A Anthony, Martha M Yearsly, et al.
Future Oncology (London, England)
|
November 12, 2024
Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study
Mehdi Hamadani, Paolo F Caimi, Brian Hess, et al.
Page
of 46
Search research articles
Search
Showing results (141-150 of 460) with videos related to
Sort By:
Page
of 46
Clinical Lymphoma, Myeloma & Leukemia
|
February 5, 2017
Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age
Binod Dhakal, Ariel Nelson, Guru Subramanian Guru Murthy, et al.
Hematology/Oncology and Stem Cell Therapy
|
October 15, 2020
Bronchoalveolar lavage-based COVID-19 testing in patients with cancer
Muhammad Bilal Abid, Saurabh Chhabra, Blake Buchan, et al.
Cytotherapy
|
October 18, 2015
Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use
Lauren Veltri, Aaron Cumpston, Alexandra Shillingburg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2015
A phase I study of midostaurin and azacitidine in relapsed and elderly AML patients
Brenda W Cooper, Tamila L Kindwall-Keller, Michael D Craig, et al.
Transplantation and Cellular Therapy
|
June 29, 2022
Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Miguel-Angel Perales, Larry D Anderson, Tania Jain, et al.
Leukemia & Lymphoma
|
October 25, 2008
Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma
Mehdi Hamadani, Farrukh T Awan, Patrick Elder, et al.
Bone Marrow Transplantation
|
August 10, 2023
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning
Shanze Arshad, Xi Fang, Kwang W Ahn, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 17, 2022
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
Paolo F Caimi, Kirit M Ardeshna, Erin Reid, et al.
Plos One
|
July 23, 2011
CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells
Kechang Liu, Bryan A Anthony, Martha M Yearsly, et al.
Future Oncology (London, England)
|
November 12, 2024
Loncastuximab tesirine in previously treated diffuse large B-cell lymphoma: A plain language summary of the LOTIS-2 study
Mehdi Hamadani, Paolo F Caimi, Brian Hess, et al.
Page
of 46